Microangiopathic hemolytic anemia classification: Difference between revisions
Jump to navigation
Jump to search
MydahSajid (talk | contribs) No edit summary |
MydahSajid (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Microangiopathic hemolytic anemia}} {{MSJ}} | {{Microangiopathic hemolytic anemia}} {{MSJ}} | ||
==Classification== | |||
[[Microangiopathic hemolytic anemia]] may be classified into primary subtype based on the [[genetic]] mutations and no known underlying [[disease]] and secondary subtype due to known underlying cause<ref name="pmid27754896">{{cite journal| author=Arnold DM, Patriquin CJ, Nazy I| title=Thrombotic microangiopathies: a general approach to diagnosis and management. | journal=CMAJ | year= 2017 | volume= 189 | issue= 4 | pages= E153-E159 | pmid=27754896 | doi=10.1503/cmaj.160142 | pmc=5266569 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27754896 }} </ref>. | [[Microangiopathic hemolytic anemia]] may be classified into primary subtype based on the [[genetic]] mutations and no known underlying [[disease]] and secondary subtype due to known underlying cause<ref name="pmid27754896">{{cite journal| author=Arnold DM, Patriquin CJ, Nazy I| title=Thrombotic microangiopathies: a general approach to diagnosis and management. | journal=CMAJ | year= 2017 | volume= 189 | issue= 4 | pages= E153-E159 | pmid=27754896 | doi=10.1503/cmaj.160142 | pmc=5266569 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27754896 }} </ref>. | ||
| Line 25: | Line 25: | ||
*** [[HIV]] | *** [[HIV]] | ||
** [[Cancer]] | ** [[Cancer]] | ||
** [[Disseminated | ** [[Disseminated intravascular coagulation]] | ||
** Solid [[organ]] or [[bone marrow]] [[transplantation]] | ** Solid [[organ]] or [[bone marrow]] [[transplantation]] | ||
** [[Nutrition]]al deficiency: [[Vitamin B12]] or [[vitamin C]] deficiency | ** [[Nutrition]]al deficiency: [[Vitamin B12]] or [[vitamin C]] deficiency | ||
Latest revision as of 22:47, 21 January 2021
|
Microangiopathic hemolytic anemia Microchapters |
|
Differentiating Microangiopathic hemolytic anemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Microangiopathic hemolytic anemia classification On the Web |
|
American Roentgen Ray Society Images of Microangiopathic hemolytic anemia classification |
|
Microangiopathic hemolytic anemia classification in the news |
|
Directions to Hospitals Treating Microangiopathic hemolytic anemia |
|
Risk calculators and risk factors for Microangiopathic hemolytic anemia classification |
Classification
Microangiopathic hemolytic anemia may be classified into primary subtype based on the genetic mutations and no known underlying disease and secondary subtype due to known underlying cause[1].
- Primary:
- Secondary:
- Malignant hypertension
- Pregnancy
- Pre-eclampsia, Eclampsia
- Thrombotic microangiopathy
- Hemolysis, elevated liver enzymes, low platelet count (HELLP syndrome)
- Drug or toxin mediated:
- Viral infections:
- Cancer
- Disseminated intravascular coagulation
- Solid organ or bone marrow transplantation
- Nutritional deficiency: Vitamin B12 or vitamin C deficiency
References
- ↑ Arnold DM, Patriquin CJ, Nazy I (2017). "Thrombotic microangiopathies: a general approach to diagnosis and management". CMAJ. 189 (4): E153–E159. doi:10.1503/cmaj.160142. PMC 5266569. PMID 27754896.